Browsing: pharma

1 marketing is getting a lifestyle makeover. Novo Nordisk and Eli Lilly are increasingly pitching their blockbuster obesity drugs less around treating a chronic disease and more around weight loss and how consumers want to look and feel. (STAT News)

CTT Pharmaceutical Holdings, Inc. (CTTH) reported another pre-revenue quarter for the six months ended June 30, 2026, with a net loss of $99,908 compared with $90,273 a year earlier.

Novartis investors have turned the spotlight on M&A after trial setbacks.Novartis’ latest trial setback serves a cautionary tale for investors betting on big pharma’s strategy of making bite-size acquisitions. (Reuters)

AI is transforming how the pharma industry approaches drug development. On average, the industry invests $2.6 billion to bring a new treatment to market, taking 12 to 15 years with a 10% success rate. But pharma pioneers are leveraging AI to rethink traditional models. Sanofi, for example, is developing a “lab-in-a-loop” that uses AI agents…

Shashank Pathak08 Sep 2026 10:08IST New Update

Regenerex Pharma, Inc. (RGPX) is a Nevada-based wound-care company focused on proprietary technologies for chronic and acute wounds, centered on its QBx™ platform and primary product, Accelerex™. Regenerex targets diabetic ulcers, pressure ulcers, burns and surgical wounds and highlights clinical data it states show high closure rates in non‑healing chronic wounds.

This is a paid press release. Contact the press release distributor directly with any inquiries.

This is a paid press release. Contact the press release distributor directly with any inquiries.